Zimbabwe has declined a substantial American health deal worth 367 million US dollars (272 million pounds) spanning five years over the United States' request for confidential data.
This rejection became public after a government memo dated December was leaked, which showed President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesman has since stated that the United States was demanding access to genetic material for scientific study and commercial purposes while was not willing to share the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged continued negotiations to secure a deal acceptable to both sides so the nation's vital HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court suspended a related health funding agreement following concerns were raised about the safety of Kenyans' medical information.
After returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral deals to enhance transparency and responsibility.
As per reports, 16 nations in Africa have to date signed these new health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to share its genetic material and health information over an extended period, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Effectively, our country would provide the basic resources for medical research with no certainty that the final treatments would be available to our people if a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks already established via the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage future pandemics.
"This mechanism is intended to ensure that when a country provides its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage continued discussions with our US partners on how future collaboration might be designed in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
Medical experts said it understood the government's concerns, but urged that talks should continue given that much of the country's Aids initiatives were funded by external financing.
"Where specific concerns exist, including those involving data governance or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," the group added.
The situation underscores the complex challenges between receiving much-needed international aid and safeguarding a country's data in an ever more data-driven world.